Paul Brannelly - Net Worth and Insider Trading
Paul Brannelly Net Worth
The estimated net worth of Paul Brannelly is at least $5 Million dollars as of 2024-09-20. Paul Brannelly is the Executive Vice President & CFO of Collegium Pharmaceutical Inc and owns about 123,436 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $5 Million. Details can be seen in Paul Brannelly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Brannelly has not made any transactions after 2018-06-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Brannelly
Paul Brannelly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Brannelly owns 2 companies in total, including Collegium Pharmaceutical Inc (COLL) , and Karyopharm Therapeutics Inc (KPTI) .
Click here to see the complete history of Paul Brannelly’s form 4 insider trades.
Insider Ownership Summary of Paul Brannelly
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2018-06-21 | Exec VP & CFO |
| KPTI | Karyopharm Therapeutics Inc | 2013-11-05 | Sr.VP,Finance,Admin,Sec.,Treas |
Paul Brannelly Latest Holdings Summary
Paul Brannelly currently owns a total of 1 stock. Paul Brannelly owns 123,436 shares of Collegium Pharmaceutical Inc (COLL) as of June 21, 2018, with a value of $5 Million.
Latest Holdings of Paul Brannelly
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical Inc | 2018-06-21 | 123,436 | 38.94 | 4,806,598 |
Holding Weightings of Paul Brannelly
Paul Brannelly Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Brannelly has made a total of 0 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 10,000 shares on June 21, 2018, which brought Paul Brannelly around $279,200.
Insider Trading History of Paul Brannelly
- 1
Paul Brannelly Trading Performance
GuruFocus tracks the stock performance after each of Paul Brannelly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Brannelly is 9.77%. GuruFocus also compares Paul Brannelly's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Brannelly within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Brannelly's insider trading performs compared to the benchmark.
Performance of Paul Brannelly
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.64 | | | | | |
| Relative Return to S&P 500(%) | 6.03 | | | | | |
Paul Brannelly Ownership Network
Paul Brannelly Owned Company Details
What does Collegium Pharmaceutical Inc do?
Who are the key executives at Collegium Pharmaceutical Inc?
Paul Brannelly is the Exec VP & CFO of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .
Collegium Pharmaceutical Inc (COLL) Insider Trades Summary
Over the past 18 months, Paul Brannelly made no insider transaction in Collegium Pharmaceutical Inc (COLL). Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 198,212 shares made by Joseph Ciaffoni , a net sale of 88,809 shares made by Shirley R. Kuhlmann , and a net sale of 141,576 shares made by Scott Dreyer .
In summary, during the past 3 months, insiders sold 29,818 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 29,818 shares. During the past 18 months, 486,885 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,885 shares.
Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Collegium Pharmaceutical Inc Insider Transactions
Paul Brannelly Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Brannelly. You might contact Paul Brannelly via mailing address: C/o Karyopharm Therapeutics Inc., 2 Mercer Road, Natick Ma 01760.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
